Middlesex University, London, UK; The Open University, Milton Keynes, UK.
University College Dublin, Ireland.
J Affect Disord. 2021 Sep 1;292:311-318. doi: 10.1016/j.jad.2021.05.031. Epub 2021 May 27.
The prevalence of depression is higher among those with diabetes than in the general population. The Patient Health Questionnaire (PHQ-9) is commonly used to assess depression in people with diabetes, but measurement invariance of the PHQ-9 across groups of people with and without diabetes has not yet been investigated.
Data from three independent cohorts from the USA (n=1,886 with diabetes, n=4,153 without diabetes), Quebec, Canada (n= 800 with diabetes, n= 2,411 without diabetes), and the UK (n=4,981 with diabetes, n=145,570 without diabetes), were used to examine measurement invariance between adults with and without diabetes. A series of multiple group confirmatory factor analyses were performed, with increasingly stringent model constraints applied to assess configural, equal thresholds, and equal thresholds and loadings invariance, respectively. One-factor and two-factor (somatic and cognitive-affective items) models were examined.
Results demonstrated that the most stringent models, testing equal loadings and thresholds, had satisfactory model fit in the three cohorts for one-factor models (RMSEA = .063 or below and CFI = .978 or above) and two-factor models (RMSEA = .042 or below and CFI = .989 or above).
Data were from Western countries only and we could not distinguish between type of diabetes.
Results provide support for measurement invariance between groups of people with and without diabetes, using either a one-factor or a two-factor model. While the two-factor solution has a slightly better fit, the one-factor solution is more parsimonious. Depending on research or clinical needs, both factor structures can be used.
与普通人群相比,糖尿病患者中抑郁症的患病率更高。患者健康问卷(PHQ-9)常用于评估糖尿病患者的抑郁状况,但尚未研究 PHQ-9 在有和无糖尿病患者群体中的跨组测量不变性。
使用来自美国(糖尿病患者 1886 例,无糖尿病患者 4153 例)、加拿大魁北克(糖尿病患者 800 例,无糖尿病患者 2411 例)和英国(糖尿病患者 4981 例,无糖尿病患者 145570 例)的三个独立队列的数据,来检验有和无糖尿病患者之间的测量不变性。进行了一系列多组验证性因素分析,分别应用越来越严格的模型约束来评估结构、相等阈值和相等阈值和负荷不变性。检验了单因素和双因素(躯体和认知情感项目)模型。
结果表明,在三个队列中,最严格的模型(检验相等负荷和阈值)对于单因素模型(RMSEA 为.063 或以下,CFI 为.978 或以上)和双因素模型(RMSEA 为.042 或以下,CFI 为.989 或以上)具有可接受的模型拟合度。
数据仅来自西方国家,且我们无法区分糖尿病的类型。
结果支持有无糖尿病患者群体之间的测量不变性,可使用单因素或双因素模型。虽然双因素模型的拟合度稍好,但单因素模型更简约。根据研究或临床需求,可以使用这两种因子结构。